Literature DB >> 11442892

A survey on the drug therapy for delirium.

T Someya1, T Endo, T Hara, G Yagi, J Suzuki.   

Abstract

Delirium, which is experienced by 10-30% of inpatients, is commonly seen in daily practice. A survey was conducted of the delirium medications, and results were obtained from 28 psychiatric departments and related facilities. Haloperidol was used in 67% cases for the treatment of delirium. Ninety-seven per cent of facilities considered haloperidol as the drug of first choice, while 57% thought this drug had few side-effects and was easy to use. However, because the use of this drug is not covered by health insurance in Japan, its use is limited. We expect that this study on medication for the treatment of delirium will be a first step in increasing the approved indications for drugs used for the treatment of delirium, and to reduce off-label use.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11442892     DOI: 10.1046/j.1440-1819.2001.00881.x

Source DB:  PubMed          Journal:  Psychiatry Clin Neurosci        ISSN: 1323-1316            Impact factor:   5.188


  5 in total

1.  The role of antipsychotics in treating delirium.

Authors:  Larry Tune
Journal:  Curr Psychiatry Rep       Date:  2002-06       Impact factor: 5.285

Review 2.  [Delirium in the intensive care unit].

Authors:  R von Haken; M Gruss; K Plaschke; M Scholz; R Engelhardt; A Brobeil; E Martin; M A Weigand
Journal:  Anaesthesist       Date:  2010-03       Impact factor: 1.041

Review 3.  Cholinesterase inhibitors for delirium.

Authors:  R Overshott; S Karim; A Burns
Journal:  Cochrane Database Syst Rev       Date:  2008-01-23

4.  Delirium as a complication of the surgical intensive care.

Authors:  Rostislav Horacek; Barbora Krnacova; Jan Prasko; Klara Latalova
Journal:  Neuropsychiatr Dis Treat       Date:  2016-09-22       Impact factor: 2.570

5.  The pharmacokinetics of mianserin suppositories for rectal administration in dogs and healthy volunteers: a pilot study.

Authors:  Shuichi Nawata; Noriko Kohyama; Naoki Uchida; Satoshi Numazawa; Masayuki Ohbayashi; Yasuna Kobayashi; Masanori Iwata; Takanori Nakajima; Hiroshi Saito; Akira Izuka; Toshinori Yamamoto
Journal:  J Pharm Health Care Sci       Date:  2016-05-17
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.